Literature DB >> 16586342

Ample use of physician-prescribed medications in Finnish elite athletes.

A Alaranta1, H Alaranta, M Heliövaara, M Airaksinen, I Helenius.   

Abstract

The present study aimed at determining the use of physician-prescribed medication in a large number of elite athletes compared with a representative control sample of the general population. Of all the athletes (N = 494) financially supported by the National Olympic Committee, 446 completed a structured questionnaire (response rate 90.3 %) in 2002. A control group (N = 1503, response rate 80.1 %) comprised an age-matched sample from the population-based study collected by the National Public Health Institute. Any prescribed medication was used by 34.5 % of the athletes and 24.9 % of the controls during the past seven days. The most frequently reported physician-prescribed medications among athletes during the previous seven days were anti-allergic medicines (12.6 % of the respondents), non-steroidal anti-inflammatory drugs (NSAIDs; 8.1 %), anti-asthmatic medicines (7.0 %), and oral antibiotics (2.7 %). The adjusted odds ratios (95 % CI) for the physician-prescribed medications used during the previous seven days was 2.42 (1.69 - 3.46), 3.63 (2.25 - 5.84), 3.42 (2.05 - 5.70), and 2.15 (1.03 - 4.45) for use of anti-allergic medication, NSAIDs, anti-asthmatic medication, and oral antibiotics, respectively, in the athletes compared with controls. Every fifth athlete reported some NSAID-related adverse effect. In conclusion, the athletes used NSAIDs, antibiotics, anti-asthmatic and anti-allergic medication significantly more often than a representative sample of age-matched controls. All these medicines have potential adverse effects that may have a deleterious impact on the maximum exercise performance of elite athletes. Adverse effects were commonly reported in connection with NSAID use.

Mesh:

Substances:

Year:  2006        PMID: 16586342     DOI: 10.1055/s-2006-923811

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  18 in total

1.  Rhabdomyolysis/myoglobinemia and NSAID during 48 h ultra-endurance exercise (adventure racing).

Authors:  Emma Wichardt; C Mikael Mattsson; Björn Ekblom; Karin Henriksson-Larsén
Journal:  Eur J Appl Physiol       Date:  2010-12-23       Impact factor: 3.078

Review 2.  Use of prescription drugs in athletes.

Authors:  Antti Alaranta; Hannu Alaranta; Ilkka Helenius
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

Review 3.  Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.

Authors:  Jaime Morente-Sánchez; Mikel Zabala
Journal:  Sports Med       Date:  2013-06       Impact factor: 11.136

4.  Preventive Health Perspective in Sports Medicine: The Trend at the Use of Medications and Nutritional Supplements during 5 Years Period between 2003 and 2008 in Football.

Authors:  Ethem Kavukcu; Kamil Mehmet Burgazlı
Journal:  Balkan Med J       Date:  2013-03-01       Impact factor: 2.021

5.  Histamine-Receptor Antagonists Slow 10-km Cycling Performance in Competitive Cyclists.

Authors:  Matthew R Ely; Dylan C Sieck; Joshua E Mangum; Emily A Larson; Leandro C Brito; Christopher T Minson; John R Halliwill
Journal:  Med Sci Sports Exerc       Date:  2019-07       Impact factor: 5.411

6.  A single dose of histamine-receptor antagonists before downhill running alters markers of muscle damage and delayed-onset muscle soreness.

Authors:  Matthew R Ely; Steven A Romero; Dylan C Sieck; Joshua E Mangum; Meredith J Luttrell; John R Halliwill
Journal:  J Appl Physiol (1985)       Date:  2016-08-04

7.  Use and abuse of medication during 2014 FIFA World Cup Brazil: a retrospective survey.

Authors:  Martin Vaso; Alexis Weber; Philippe M Tscholl; Astrid Junge; Jiri Dvorak
Journal:  BMJ Open       Date:  2015-09-10       Impact factor: 2.692

Review 8.  High prevalence of medication use in professional football tournaments including the World Cups between 2002 and 2014: a narrative review with a focus on NSAIDs.

Authors:  Philippe M Tscholl; Martin Vaso; Alexis Weber; Jiri Dvorak
Journal:  Br J Sports Med       Date:  2015-05       Impact factor: 13.800

9.  Consumption of analgesics before a marathon and the incidence of cardiovascular, gastrointestinal and renal problems: a cohort study.

Authors:  Michael Küster; Bertold Renner; Pascal Oppel; Ursula Niederweis; Kay Brune
Journal:  BMJ Open       Date:  2013-04-19       Impact factor: 2.692

10.  The use of medication and nutritional supplements during FIFA World Cups 2002 and 2006.

Authors:  P Tscholl; A Junge; J Dvorak
Journal:  Br J Sports Med       Date:  2008-02-28       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.